Arie Belldegrun's Net Worth

$603 Million

Estimate Recalculated Feb 16, 2024 08:36PM EST

Who is Arie Belldegrun?

Arie Belldegrun has an estimated net worth of $603 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., Cougar Biotechnology, Inc., Paramount Acquisition Corp, Kronos Bio, Inc., Ginkgo Bioworks Holdings, Inc., UroGen Pharma Ltd., Kite Pharma, Inc., Nile Therapeutics, Inc., Hana Biosciences Inc, and Arno Therapeutics, Inc.

SEC CIK

Arie Belldegrun's CIK is 0001296549

Past Insider Trading and Trends

2013 was Arie Belldegrun's most active year for acquiring shares with 37 total transactions. Arie Belldegrun's most active month to acquire stocks was the month of September. 2009 was Arie Belldegrun's most active year for disposing of shares, totalling 13 transactions. Arie Belldegrun's most active month to dispose stocks was the month of September. 2021 saw Arie Belldegrun paying a total of $6,938,992.52 for 669,006 shares, this is the most they've acquired in one year. In 2017 Arie Belldegrun cashed out on 3,782,376 shares for a total of $597,611,792.18, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Allogene Therapeutics, Inc. (ALLO) Snapshot price: $4.105

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+12.81%
211.97K
1.87M
Jan 25
Form 4
+344.97%
1.28M
1.65M
Mar 22
Form 4/A
0
4.71M
Mar 14
Form 4
0
4.71M
Mar 14
Form 4
0
0
Mar 23
Form 4
+387.60%
155.04K
$12.60
$1,953,491.40
195.04K
Jan 12
Form 4
+185.85%
379.07K
$18.22
$6,906,582.52
583.03K
May 24
Form 4
+35.68%
53.63K
203.97K
Mar 26
Form 4
+8.65%
146.38K
$47.00
$6,879,954.00
1.84M
Jun 4
Form 4
0
0
Mar 18
Form 4
-9.94%
-585.52K
5.31M
Scheduled
May 13
Form 4
-9.04%
-585.52K
5.89M
Scheduled
Apr 26
Form 4
+329.52%
115.33K
150.33K
Mar 13
Form 4/A
+12.99%
194.44K
$18.00
$3,500,010.00
1.69M
Oct 15
Form 4
+214.81%
7.66M
$18.00
$630,000.00
11.23M
Oct 15
Form 3
0
0
No matching records found

Cougar Biotechnology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-357.33K
$43.00
-$15,365,276.00
0
Jul 3
Form 4
0
0
Jun 17
Form 4
+8.38%
5K
$27.00
$134,997.00
64.66K
Feb 21
Form 4
+33.58%
15K
$30.50
$457,500.00
59.66K
Dec 18
Form 4
+9.03%
3.7K
$23.90
$88,430.00
44.66K
Jun 18
Form 4
0
0
Jun 11
Form 4
+20.97%
7.1K
$21.10
$149,810.00
40.96K
May 8
Form 4
+79.52%
15K
$18.33
$274,975.00
33.86K
Feb 26 - Feb 27
Form 3/A
0
0
Form 4
18.86K
18.86K
Dec 29
Form 4
0
0
Jun 28 - Sep 6
Form 3/A
0
0
Form 3
0
0
No matching records found

Paramount Acquisition Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jan 24
Form 4
0
0
Jan 17 - Jan 18
Form 4
0
0
Jan 11 - Jan 12
Form 3
0
0
No matching records found

Kronos Bio, Inc. (KRON) Snapshot price: $1.07

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 22
Form 4
0
0
Jun 22
Form 4
0
0
Jun 22
Form 4
+1,070.62%
2.74M
$16.15
2.99M
Oct 14
Form 3
0
0
No matching records found

Ginkgo Bioworks Holdings, Inc. (DNA) Snapshot price: $1.23

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 16
Form 4
+378.43%
70.92K
89.66K
Jun 10
Form 3/A
0
0
Form 3
0
0
No matching records found